Zixu Wang (he/him/his)

Senior Manager, Data Science
Bicycle Therapeutics

Poster(s):

• (T-031) Zelenectide Pevedotin, a Bicycle Drug Conjugate (BDC®), Does Not Present Clinically Meaningful QT Prolongation Risk as Demonstrated by A Concentration-QTc (C-QTc) Analysis
  Tuesday, October 21, 2025

  7:00 AM - 1:45 PM MDT